CMS Modified NCD 9 for Phaco-Emulsification Cataract Extraction — What Billing Teams Need to Know in 2026
TL;DR: The Centers for Medicare & Medicaid Services modified NCD 9, the National Coverage Determination governing phaco-emulsification cataract extraction, with an effective date of January 9, 2026. The policy confirms Medicare reimbursement for phaco-emulsification as an accepted surgical technique — here's what your billing team needs to understand right now.
The CMS phaco-emulsification cataract extraction coverage policy falls under the Physicians' Services benefit category. NCD 9 in the CMS system establishes that phaco-emulsification — the ultrasonic technique used in the vast majority of modern cataract surgeries — is a covered, accepted procedure for Medicare beneficiaries. This modification does not introduce new exclusions. It does, however, signal a policy review cycle that billing teams should track.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Phaco-Emulsification Procedure — Cataract Extraction |
| Policy Code | NCD 9 |
| Change Type | Modified |
| Effective Date | January 9, 2026 |
| Impact Level | Low (coverage position unchanged; confirmatory update) |
| Specialties Affected | Ophthalmology, Ambulatory Surgery Centers, Outpatient Hospital Facilities |
| Key Action | Confirm your cataract extraction claims align with medical necessity documentation requirements under NCD 9 before billing for dates of service on or after January 9, 2026. |
CMS Phaco-Emulsification Coverage Criteria and Medical Necessity Requirements 2026
NCD 9 is the National Coverage Determination governing whether Medicare pays for cataract removal using the phaco-emulsification technique. The policy is grounded in recommendations from authoritative sources in ophthalmology. CMS treats phaco-emulsification as an accepted, standard-of-care procedure for cataract extraction.
The coverage policy is straightforward: Medicare reimburses necessary services furnished in connection with cataract extraction using phaco-emulsification. That phrase — "necessary services" — is doing the real work here. Medical necessity is not automatic. Your documentation must support that the cataract warrants surgical intervention.
General Billing Context — Not Stated in NCD 9: NCD 9 does not enumerate specific medical necessity criteria. In general Medicare billing practice, cataract surgery documentation commonly addresses best-corrected visual acuity, functional complaints, and the clinical judgment of the treating ophthalmologist. These reflect standard industry documentation practice, not criteria listed in the NCD itself. Your MAC's LCD is the right source for any specific thresholds that apply to your claims.
NCD 9 does not address prior authorization requirements. Your facility's specific payer contracts and any applicable MAC-level policies may impose prior auth requirements. Verify this at the MAC level before scheduling surgery for Medicare beneficiaries.
The 2026 modification does not appear to narrow coverage. It reads as a policy maintenance update — the coverage position is preserved, not tightened. That said, a policy touch during a review cycle sometimes precedes more substantive changes. Watch NCD 9 closely through the rest of 2026.
Coverage Indications at a Glance
The policy summary for NCD 9 does not enumerate indication-by-indication criteria. It establishes blanket coverage for phaco-emulsification cataract extraction as a technique, subject to medical necessity. The table below reflects the scope of coverage as stated.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Cataract extraction via phaco-emulsification technique | Covered | Not specified in NCD 9 | Medical necessity documentation required; MAC LCD may apply |
| Necessary services in connection with phaco-emulsification | Covered | Not specified in NCD 9 | Scope of "necessary services" determined at claim level |
CMS Phaco-Emulsification Billing Guidelines and Action Items 2026
The policy modification is low-impact in terms of coverage change. But a low-impact update still requires active billing management. Here's what to do.
| # | Action Item |
|---|---|
| 1 | Confirm your MAC's LCD is still aligned with NCD 9. NCD 9 sets the national floor. Your Medicare Administrative Contractor may have a more detailed LCD on cataract surgery that specifies visual acuity thresholds, functional criteria, or documentation requirements. Pull that LCD now and compare it against your current intake and documentation workflows. |
| 2 | Audit your medical necessity documentation for cataract claims dated on or after January 9, 2026. The effective date of January 9, 2026 is the trigger point for this modified version. Review operative notes, pre-op evaluations, and referring physician documentation to confirm they support medical necessity under your MAC's criteria. |
| 3 | Update your billing guidelines reference materials to reflect the January 9, 2026 modification. If your team maintains internal policy reference documents or charge capture guides for ophthalmology, update them to reflect the January 9, 2026 modification date. Outdated references cause inconsistent billing and increase claim denial risk. |
| 4 | Verify CPT code assignment for cataract extraction procedures. NCD 9 does not list specific CPT or HCPCS codes. That means your billing team must map to the correct extracapsular cataract extraction codes using the CPT code set directly. Select codes based on the operative report — not a template. The NCD's silence on codes is not a signal to guess. |
| 5 | Do not treat this modification as a coverage expansion. The plain language of NCD 9 confirms existing coverage — it does not add new covered indications or remove existing limitations. Billing for services that go beyond the current coverage position based on this update would be a mistake. If you have questions about borderline medical necessity cases, loop in your compliance officer before the claim goes out. |
| 6 | Watch for secondary payer billing implications. Cataract extraction billing often involves coordination between Medicare and a Medigap or Medicare Advantage plan. Confirm that the NCD 9 modification does not conflict with the coverage policy of any secondary or Medicare Advantage plan your patient population uses. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Phaco-Emulsification Cataract Extraction Under NCD 9
The policy data for NCD 9 does not include specific CPT, HCPCS, or ICD-10 codes. This is a known characteristic of some older NCDs — they establish coverage intent without enumerating a code list.
This is not a billing shortcut. The absence of codes in NCD 9 means your team carries more responsibility for accurate code selection. Assign codes based on operative report documentation and current CPT guidelines, not assumptions.
CPT and HCPCS Codes
| Code | Type | Description |
|---|---|---|
| Not listed in NCD 9 | — | CMS NCD 9 does not enumerate specific CPT or HCPCS codes |
ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| Not listed in NCD 9 | CMS NCD 9 does not enumerate specific ICD-10-CM codes |
Your ophthalmology billing team should map diagnosis codes from the clinical record per your MAC's LCD guidance. If your practice needs a code crosswalk, your MAC's LCD is the right reference — not NCD 9 alone.
What This Update Really Means for Cataract Extraction Billing
The honest read on NCD 9's January 2026 modification: this is a housekeeping update. CMS is not signaling a coverage restriction. The language — that phaco-emulsification is an accepted procedure based on ophthalmology's authoritative sources — has been the agency's position for years.
But that framing cuts both ways. Because this is a confirmatory update with no new criteria, the real risk for billing teams is complacency. Phaco-emulsification is among the highest-volume surgical procedures in Medicare. High volume means high audit exposure.
Claim denial in cataract surgery most often traces back to weak medical necessity documentation — not wrong codes. The NCD's language of "necessary services" is a direct hook for post-payment review. Make sure your pre-op documentation would survive scrutiny.
If your practice is billing phaco-emulsification for Medicare beneficiaries at scale and you haven't done a documentation audit recently, this policy update is your prompt to do one now. Talk to your compliance officer about conducting a focused review of cataract surgery records from the past 12 months.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.